See more : Kitron ASA (0F0J.L) Income Statement Analysis – Financial Results
Complete financial analysis of Linike Medical Group Ltd (LNMG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Linike Medical Group Ltd, a leading company in the Shell Companies industry within the Financial Services sector.
- Itonis, Inc. (ITNS) Income Statement Analysis – Financial Results
- BASE CO., LTD. (4481.T) Income Statement Analysis – Financial Results
- Federal National Mortgage Association (FNMAN) Income Statement Analysis – Financial Results
- Mani, Inc. (7730.T) Income Statement Analysis – Financial Results
- Industrial Tech Acquisitions II, Inc. (ITAQW) Income Statement Analysis – Financial Results
Linike Medical Group Ltd (LNMG)
About Linike Medical Group Ltd
Linike Medical Group Ltd engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd in August 2021. Linike Medical Group Ltd is based in Calgary, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2018 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|
| Revenue | 8.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 69.30K |
| Cost of Revenue | 65.11K | 0.00 | 0.00 | 0.00 | 0.00 | 593.00 | 26.99K |
| Gross Profit | 8.89M | 0.00 | 0.00 | 0.00 | 0.00 | -593.00 | 42.31K |
| Gross Profit Ratio | 99.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 61.06% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 214.51 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 214.30K | 0.00 |
| SG&A | 7.90M | 65.98K | 29.86K | 88.57K | 1.08K | 214.51K | 130.27K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.90M | 65.98K | 29.86K | 88.57K | 1.08K | 214.51K | 130.27K |
| Cost & Expenses | 7.96M | 65.98K | 29.86K | 88.57K | 1.08K | 215.10K | 157.26K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 65.11K | 228.49K | 236.56K | 206.30K | 0.00 | 593.00 | 2.16K |
| EBITDA | 1.06M | -65.98K | -29.86K | -88.57K | -1.08K | -214.51K | -85.80K |
| EBITDA Ratio | 11.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -123.81% |
| Operating Income | 991.04K | -65.98K | -29.86K | -88.57K | -1.08K | -215.10K | -87.96K |
| Operating Income Ratio | 11.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -126.92% |
| Total Other Income/Expenses | 0.00 | 1.00 | -1.00 | 4.00 | 5.00 | -212.67K | -31.41K |
| Income Before Tax | 991.04K | -65.98K | -29.86K | -88.57K | -1.08K | -427.77K | -88.35K |
| Income Before Tax Ratio | 11.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -127.49% |
| Income Tax Expense | -1.00 | -228.49K | -236.56K | -206.30K | 0.00 | -3.00 | -3.00 |
| Net Income | 991.04K | -65.98K | -29.86K | -88.57K | -1.08K | -427.77K | -88.35K |
| Net Income Ratio | 11.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -127.49% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.25 | -0.32 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.25 | -0.32 |
| Weighted Avg Shares Out | 668.95M | 635.40M | 509.47M | 96.93M | 3.47M | 1.73M | 272.32K |
| Weighted Avg Shares Out (Dil) | 668.95M | 635.40M | 509.47M | 96.93M | 3.47M | 1.73M | 272.32K |
Source: https://incomestatements.info
Category: Stock Reports